Hansa Biopharma AB (OSTO:HNSA) Change In Inventory : kr0.0 Mil (TTM As of Mar. 2024)

View and export this data going back to 2007. Start your Free Trial

What is Hansa Biopharma AB Change In Inventory?

Hansa Biopharma AB's change in inventory for the quarter that ended in Mar. 2024 was kr0.0 Mil. It means Hansa Biopharma AB's inventory stayed the same from Dec. 2023 to Mar. 2024 .

Hansa Biopharma AB's change in inventory for the fiscal year that ended in Dec. 2023 was kr0.0 Mil. It means Hansa Biopharma AB's inventory stayed the same from Dec. 2022 to Dec. 2023 .

Hansa Biopharma AB's Total Inventories for the quarter that ended in Mar. 2024 was kr1.2 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Hansa Biopharma AB's Days Inventory for the quarter that ended in Mar. 2024 was 6.82.

Inventory Turnover measures how fast the company turns over its inventory within a year. Hansa Biopharma AB's Inventory Turnover for the quarter that ended in Mar. 2024 was 13.38.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Hansa Biopharma AB's Inventory-to-Revenue for the quarter that ended in Mar. 2024 was 0.02.

Hansa Biopharma AB Change In Inventory Historical Data

The historical data trend for Hansa Biopharma AB's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hansa Biopharma AB Change In Inventory Chart

Hansa Biopharma AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Inventory

Get a 7-Day Free Trial

Hansa Biopharma AB Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Inventory	Get a 7-Day Free Trial															-	-	-	-	-

Hansa Biopharma AB Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.0 Mil.

Hansa Biopharma AB (OSTO:HNSA) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Hansa Biopharma AB's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	1.357	/	18.158	*	365 / 4
	=	6.82

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Hansa Biopharma AB's Inventory Turnover for the quarter that ended in Mar. 2024 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	18.158	/	1.357
	=	13.38

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Hansa Biopharma AB's Inventory to Revenue for the quarter that ended in Mar. 2024 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	1.357	/	55.981
	=	0.02

Hansa Biopharma AB Change In Inventory Related Terms

Thank you for viewing the detailed overview of Hansa Biopharma AB's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Hansa Biopharma AB (OSTO:HNSA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hansa Biopharma AB (OSTO:HNSA) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

HNSBF:USA 0RC7:UK 24H:Germany

Address

Scheelevagen 22, Lund, SWE, 223 63

Website

https://www.hansabiopharma.com

Hansa Biopharma AB is a biopharmaceutical company that develops immunomodulatory treatments for enabling transplantations and rare immunoglobulin G (IgG)-mediated autoimmune conditions, transplant rejection, and cancer. The company's product candidate, imlifidase, is an antibody-cleaving enzyme being developed to enable kidney transplantation in sensitized patients and further developed for use in other organ and tissue transplantation as well as acute autoimmune indications. It operates in Sweden, other European countries, and the U.S. The group generates the majority of its revenue from product sales.

Hansa Biopharma AB (OSTO:HNSA) Headlines

No Headlines